Home › Ablacon Inc. › Ablacon™ Mapping Catheter
Ablacon™ Mapping Catheter
Ablacon Inc. · Model AB-0003-50 · UDI-DI 00860457001544
MTD
Prescription
10
510(k) clearances
1,862
Adverse events (30 deaths)
9
Recalls
31
Facilities
Description
The Ablacath™ Mapping Catheter may be used to detect electrical potentials from the endocardial surfaces of the heart. These signals may be used for analysis with mapping systems. The Ablacath™ Mapping Catheter may also be used to deliver externally generated pacing stimuli.
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2022-04-28 | Abbott | Incorrect product labeling. |
| 2020-04-22 | BIOSENSE WEBSTER | Mapping Catheter can become entrapped in the cardiac valvular apparatus while the user is attempting to create an electroanatomic map. |
| 2017-05-17 | Biosense Webster, Inc. | Contraindication language updated in the Instructions For Use (IFU) to indicate that Pentaray Catheters should not be used in patients with prosthetic valves. |
| 2017-05-17 | Biosense Webster, Inc. | Contraindication language updated in the Instructions For Use (IFU) to indicate that Pentaray Catheters should not be used in patients with prosthetic valves. |
| 2016-04-14 | Biosense Webster, Inc. | Biosense Webster is recalling the Pentaray Catheters to clarify the contraindication language in the Instructions For Use (IFU) and product labeling for this catheter relative to p |
| 2016-04-14 | Biosense Webster, Inc. | Biosense Webster is recalling the Pentaray Catheters to clarify the contraindication language in the Instructions For Use (IFU) and product labeling for this catheter relative to p |
| 2015-08-12 | Abbott Electrophysiology | The expiration date was incorrectly printed on the pouch/box labels of 19 products that were shipped to customer sites. The manufacturing date was accidentally used (copied) for th |
| 2014-02-20 | Biosense Webster, Inc. | Biosense Webster is recalling the PentaRay Nav Catheter because it has the potential to have partial tip separation from the catheter shaft. Biosense Webster is expanding the reca |
| 2005-02-14 | Boston Scientific | The coating on the product's surface can generate debris, which could then move from the heart towards the brain, resulting in Ischemic events. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.
